FALCONE, GIUSEPPE ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 14
AS - Asia 4
Totale 18
Nazione #
US - Stati Uniti d'America 14
HK - Hong Kong 3
LB - Libano 1
Totale 18
Città #
Henderson 2
Ashburn 1
Beirut 1
Buffalo 1
Herndon 1
Los Angeles 1
New York 1
Rochester 1
San Francisco 1
Secaucus 1
Totale 11
Nome #
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance?, file e18b8791-e3cc-d302-e053-1705fe0a27c8 7
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623, file e18b8791-e3ca-d302-e053-1705fe0a27c8 5
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients, file e18b8791-ecc9-d302-e053-1705fe0a27c8 3
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients, file e18b8791-ee01-d302-e053-1705fe0a27c8 3
Totale 18
Categoria #
all - tutte 249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202318 4 0 3 5 0 1 2 3 0 0 0 0
Totale 18